WITHDRAWN: lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy.
Linc00173
YB1
glucose metabolism
in vitro
in vivo
long noncoding RNA
molecular mechanisms
multidrug resistance
small cell lung cancer
therapeutic targets
tissue samples
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581
Informations de publication
Date de publication:
08 11 2021
08 11 2021
Historique:
received:
06
04
2021
revised:
05
09
2021
accepted:
03
11
2021
pubmed:
12
11
2021
medline:
12
11
2021
entrez:
11
11
2021
Statut:
aheadofprint
Résumé
This article has been withdrawn at the request of the editor-in-chief.
Following publication of this article, the editor-in-chief discovered evidence of image duplication in Figures 1I, 1J, 3F, S5B, and S6B. Given the duplication of several western blots representing several gene products, the editor-in-chief has lost faith in the findings presented in this article. The authors maintain that these image duplications were the result of errors in file management and do not affect the conclusions of the study.
The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Identifiants
pubmed: 34763086
pii: S1525-0016(21)00574-8
doi: 10.1016/j.ymthe.2021.11.003
pii:
doi:
Types de publication
Journal Article
Retracted Publication
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : ExpressionOfConcernIn
Type : RetractionIn
Informations de copyright
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare that they have no competing interests.